CLINICAL ROLE -
Zavegepant Is A Promising Frontier in Acute Migraine Treatment
As a CGRP receptor antagonist, zavegepant intervenes during the active phase of migraine, providing a targeted and prompt response to alleviate symptoms.
Read More
Cardiovascular Outcomes in Patients Intolerant to Statins Treated with Bempedoic Acid
In December 2023, the FDA granted expanded indications for bempedoic acid and bempedoic acid plus ezetimibe in the treatment of primary hyperlipidemia.
Gepirone Offers New Option for Major Depressive Disorder
Gepirone does not induce sexual dysfunction, a common limitation associated with SSRIs.
Pharmacists Play Crucial Role in Antimicrobial Stewardship
Available data indicate that as much as 50% of all antibiotics prescribed for individuals may be either unnecessary or not administered in the most effective manner as recommended.